129 related articles for article (PubMed ID: 34788864)
21. Cigarette smoking and progression of IgA nephropathy.
Yamamoto R; Nagasawa Y; Shoji T; Iwatani H; Hamano T; Kawada N; Inoue K; Uehata T; Kaneko T; Okada N; Moriyama T; Horio M; Yamauchi A; Tsubakihara Y; Imai E; Rakugi H; Isaka Y
Am J Kidney Dis; 2010 Aug; 56(2):313-24. PubMed ID: 20471735
[TBL] [Abstract][Full Text] [Related]
22. Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy.
Russo E; Drovandi S; Salvidio G; Verzola D; Esposito P; Garibotto G; Viazzi F
Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2343-2350. PubMed ID: 32912790
[TBL] [Abstract][Full Text] [Related]
23. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ
Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674
[TBL] [Abstract][Full Text] [Related]
24. Hematuria was a high risk for renal progression and ESRD in immunoglobulin a nephropathy: a systematic review and meta-analysis.
He P; Wang H; Huang C; He L
Ren Fail; 2021 Dec; 43(1):488-499. PubMed ID: 33685345
[No Abstract] [Full Text] [Related]
25. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
Chai L; Cai K; Wang K; Luo Q
J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
[TBL] [Abstract][Full Text] [Related]
26. A Validation Study Comparing Risk Prediction Models of IgA Nephropathy.
Ouyang Y; Zhao Z; Li G; Luo H; Xu F; Shao L; Chen Z; Yu S; Jin Y; Xu J; Shi M; Hussain HMJ; Du W; Fang Z; Pan X; Wang W; Xie J; Chen N
Front Immunol; 2021; 12():753901. PubMed ID: 34721428
[TBL] [Abstract][Full Text] [Related]
27. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy.
Wang S; Dong L; Pei G; Jiang Z; Qin A; Tan J; Tang Y; Qin W
Front Immunol; 2021; 12():700224. PubMed ID: 34456912
[TBL] [Abstract][Full Text] [Related]
28. The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy.
Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Nagata M; Tsuchimoto A; Hirakata H; Kitazono T; Tsuruya K
Clin Exp Nephrol; 2016 Oct; 20(5):689-698. PubMed ID: 26564155
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for pregnancy outcomes in patients with IgA nephropathy: a matched cohort study.
Liu Y; Ma X; Lv J; Shi S; Liu L; Chen Y; Zhang H
Am J Kidney Dis; 2014 Nov; 64(5):730-6. PubMed ID: 25134778
[TBL] [Abstract][Full Text] [Related]
30. Primary glomerulonephritis: an update on renal survival and determinants of progression.
Moranne O; Watier L; Rossert J; Stengel B;
QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
[TBL] [Abstract][Full Text] [Related]
31. Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy.
Chen T; Li X; Li Y; Xia E; Qin Y; Liang S; Xu F; Liang D; Zeng C; Liu Z
Am J Kidney Dis; 2019 Sep; 74(3):300-309. PubMed ID: 31031086
[TBL] [Abstract][Full Text] [Related]
32. A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study.
Goto M; Wakai K; Kawamura T; Ando M; Endoh M; Tomino Y
Nephrol Dial Transplant; 2009 Oct; 24(10):3068-74. PubMed ID: 19515800
[TBL] [Abstract][Full Text] [Related]
33. Association of C4d deposition with clinical outcomes in IgA nephropathy.
Espinosa M; Ortega R; Sánchez M; Segarra A; Salcedo MT; González F; Camacho R; Valdivia MA; Cabrera R; López K; Pinedo F; Gutierrez E; Valera A; Leon M; Cobo MA; Rodriguez R; Ballarín J; Arce Y; García B; Muñoz MD; Praga M;
Clin J Am Soc Nephrol; 2014 May; 9(5):897-904. PubMed ID: 24578331
[TBL] [Abstract][Full Text] [Related]
34. A Rare Presentation of Immunoglobulin A Nephropathy: Acute Kidney Injury.
Oruc M; Durak H; Yalin SF; Seyahi N; Altıparmak MR; Trabulus S
Nephron; 2017; 137(1):8-14. PubMed ID: 28743127
[TBL] [Abstract][Full Text] [Related]
35. A J-shaped association between serum uric acid levels and poor renal survival in female patients with IgA nephropathy.
Matsukuma Y; Masutani K; Tanaka S; Tsuchimoto A; Fujisaki K; Torisu K; Katafuchi R; Hirakata H; Tsuruya K; Kitazono T
Hypertens Res; 2017 Mar; 40(3):291-297. PubMed ID: 27733763
[TBL] [Abstract][Full Text] [Related]
36. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy.
Wu C; Wang AY; Li G; Wang L
BMC Nephrol; 2018 Dec; 19(1):381. PubMed ID: 30594167
[TBL] [Abstract][Full Text] [Related]
37. Pregnancy outcomes in women with immunoglobulin A nephropathy: a nationwide population-based cohort study.
Jarrick S; Lundberg S; Stephansson O; Symreng A; Bottai M; Höijer J; Ludvigsson JF
J Nephrol; 2021 Oct; 34(5):1591-1598. PubMed ID: 33683676
[TBL] [Abstract][Full Text] [Related]
38. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH
J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358
[TBL] [Abstract][Full Text] [Related]
40. IgA Nephropathy Recurrence after Kidney Transplantation: Role of Recipient Age and Human Leukocyte Antigen-B Mismatch.
Rodas LM; Ruiz-Ortiz E; Garcia-Herrera A; Pereira A; Blasco M; Ventura-Aguiar P; Viñas Gomis O; Egri N; De Sousa E; Palou E; Diekmann F; Poch E; Campistol JM; Quintana LF
Am J Nephrol; 2020; 51(5):357-365. PubMed ID: 32187607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
